161 related articles for article (PubMed ID: 36704852)
1. [Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
Kang K; Zhang J; Zhang X; Chen Z
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36704852
[TBL] [Abstract][Full Text] [Related]
2. [Retracted] MicroRNA‑326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
Hu S; Ran Y; Chen W; Zhang Y; Xu Y
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36928745
[TBL] [Abstract][Full Text] [Related]
3. [Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
Liu X; Wang Y; Zhao J
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36043516
[TBL] [Abstract][Full Text] [Related]
4. [Retracted] MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
Wu S; Ai N; Liu Q; Zhang J
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35730602
[TBL] [Abstract][Full Text] [Related]
5. [Retracted] MicroRNA‑379 acts as a tumor suppressor in non‑small cell lung cancer by targeting the IGF‑1R‑mediated AKT and ERK pathways.
Zhou F; Nie L; Feng D; Guo S; Luo R
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35642683
[TBL] [Abstract][Full Text] [Related]
6. [Retracted] MicroRNA‑655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.
Zhang M; Li Q; Pan Y; Wang H; Liu G; Yin H
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 35946459
[TBL] [Abstract][Full Text] [Related]
7. [Retracted] MicroRNA‑663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4.
Liu Y; Jiao D; Tian Z
Mol Med Rep; 2023 May; 27(5):. PubMed ID: 37052236
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] MicroRNA‑876‑5p inhibits the progression of glioblastoma multiforme by directly targeting Forkhead box M1.
Wang L; Lu J; Zhang H; Lyu X; Sun Z
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35796017
[TBL] [Abstract][Full Text] [Related]
9. [Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642668
[TBL] [Abstract][Full Text] [Related]
10. [Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004468
[TBL] [Abstract][Full Text] [Related]
11. [Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195847
[TBL] [Abstract][Full Text] [Related]
12. [Retracted] miR‑200b inhibits migration and invasion in non‑small cell lung cancer cells via targeting FSCN1.
Xiao P; Liu W; Zhou H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132372
[TBL] [Abstract][Full Text] [Related]
13. [Retracted] MicroRNA‑466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin.
Jia C; Tang D; Sun C; Yao L; Li F; Hu Y; Zhang X; Wu D
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35762328
[TBL] [Abstract][Full Text] [Related]
14. [Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.
Pang L; Li B; Zheng B; Niu L; Ge L
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014683
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] MicroRNA‑760 inhibits cell proliferation and invasion of colorectal cancer by targeting the SP1‑mediated PTEN/AKT signalling pathway.
Li X; Ding Y; Liu N; Sun Q; Zhang J
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35762320
[TBL] [Abstract][Full Text] [Related]
16. [Retracted] MicroRNA‑362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
Shi C; Zhang Z
Oncol Rep; 2024 Apr; 51(4):. PubMed ID: 38334137
[TBL] [Abstract][Full Text] [Related]
17. [Retracted] MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109991
[TBL] [Abstract][Full Text] [Related]
18. [Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.
Zhao Y; Pang W; Yang N; Hao L; Wang L
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36043533
[TBL] [Abstract][Full Text] [Related]
19. [Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A.
Liang S; Zhang N; Deng Y; Chen L; Zhang Y; Zheng Z; Luo W; Lv Z; Li S; Xu T
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34812473
[TBL] [Abstract][Full Text] [Related]
20. [Retracted] miR‑489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways.
Wang W; Zhang L; Gao W; Zhang D; Zhao Z; Bao Y
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
